Verus Pharmaceuticals

From WikiMD's WELLNESSPEDIA


Verus Pharmaceuticals was a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of pediatric and allergy-related conditions. The company was based in San Diego, California.

History[edit]

Verus Pharmaceuticals was founded with the aim of addressing unmet medical needs in the pediatric population, particularly in the areas of asthma and allergy. The company sought to develop innovative solutions that would improve the quality of life for children suffering from these conditions.

Products[edit]

Verus Pharmaceuticals developed several products aimed at treating pediatric asthma and allergy. One of their notable products was an epinephrine auto-injector designed for the emergency treatment of anaphylaxis. This product was intended to be user-friendly and specifically tailored for use in children.

Acquisition[edit]

In 2008, Verus Pharmaceuticals sold its pediatric asthma development programs to AstraZeneca, a global biopharmaceutical company. This acquisition allowed AstraZeneca to expand its portfolio in the respiratory field and continue the development of Verus's innovative products.

Impact[edit]

The work of Verus Pharmaceuticals contributed to advancements in the treatment of pediatric asthma and allergy. By focusing on the specific needs of children, the company played a role in improving therapeutic options and outcomes for young patients.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.